Table 1.

MST and ILS of treated a MKN45 peritoneally disseminated mouse model from the data of Figure 1A

Treatment	Doses	MST (d)	ILS (%)
Control	—	48.9 ± 3.5	—
DFP‐10825	2.5 µg TS shRNA	49.3 ± 3.9	0.8
	5.0 µg TS shRNA	52.8 ± 3.6	8.0
	10 µg TS shRNA	53.6 ± 3.9	9.6
	20 µg TS shRNA	56.6 ± 4.2**,$$	15.7

MST (d) and ILS (%) were determined from the data shown in Figure 1A. The MSTs are represented as the mean ± SD (n = 9‐10, **P < .01 vs control, ^$$ P < .01 vs 2.5 µg TS shRNA). The ILSs were calculated using a formula described in Section 2.

Abbreviations: ILS, increased life span; MST, mean survival time; TS, thymidylate synthase.